表紙
市場調査レポート

女性の健康の世界市場:2016年〜2020年

Global Womens Health Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 307873
出版日 ページ情報 英文 65 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
女性の健康の世界市場:2016年〜2020年 Global Womens Health Market 2016-2020
出版日: 2016年04月12日 ページ情報: 英文 65 Pages
概要

世界の女性の健康市場は、2016年〜2020年のCAGR (複合年間成長率) で、3%以上の成長が見込まれています。多くの国が医療施設を改善し、それに伴って、市場も前向きな見通しが予測されています。

当レポートでは、世界の女性の健康市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 調査範囲

  • 市場概要
  • 主要ベンダー製品

第3章 市場調査手法

  • 調査手法
  • 経済指標

第4章 イントロダクション

  • 主な市場ハイライト

第5章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 市場区分:適用別

  • 市場概要
  • 閉経後骨粗しょう症
  • 避妊薬
  • 不妊症
  • 更年期障害
  • 子宮内膜症
  • 多嚢胞性卵巣症候群

第7章 地理区分

  • 市場概要
  • 南北アメリカ
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ

第8章 市場促進要因

第9章 促進要因の影響

第10章 市場の課題

第11章 促進要因と課題の影響

第12章 市場動向

第13章 ベンダー情勢

  • 競合シナリオ

第14章 主要ベンダー分析

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
  • その他の有力ベンダー

第15章 付録

  • 略語リスト

第16章 Technavioについて

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR9224

About Global Directed Energy Weapons Market 2016-2020

A directed-energy weapon (DEW) is the future weapon system that emits highly focused energy for target destruction. The potential applications of this advanced technology include anti-personnel weapon systems, missile defense system, and the disabling of lightly armored vehicles. The use of DEW systems is much more cost-effective than the massive cost associated with a single missile launch. With fast-track innovations in the military technology, such weapons are tools for future warfare.

Technavio's analysts forecast the global DEW market to grow at a CAGR of 29.03% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global directed energy weapons (DEW) market for 2016-2020.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Directed Energy Weapons Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BAE Systems
  • Boeing
  • Lockheed Martin Corp.
  • Northrop Grumman Corp.
  • Raytheon Co

Other Prominent Vendors

  • Finmeccanica
  • Israel Aerospace Industries
  • Saab
  • Thales Group

Market driver

  • Growing demand for non-lethal weapons
  • For a full, detailed list, view our report

Market challenge

  • Defense budget cuts
  • For a full, detailed list, view our report

Market trend

  • Increasing investments in R&D
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Market overview
  • Global postmenopausal osteoporosis market
  • Global contraceptives market
  • Global infertility market
  • Global menopause market
  • Global endometriosis market
  • Global polycystic ovary syndrome market

PART 07: Geographical segmentation

  • Market overview
  • Women's health market in Americas
  • Women's health market in Europe
  • Women's health market in APAC
  • Women's health market in MEA

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Global women's health market segmentation
  • Exhibit 02: Product offerings
  • Exhibit 03: Global women's health market 2015-2020 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global women's health market segmentation by application 2015
  • Exhibit 06: Global women's health market segmentation by application 2020
  • Exhibit 07: Global women's health market by application 2015-2020 ($ billions)
  • Exhibit 08: Global women's health market by application 2015-2020 (% share)
  • Exhibit 09: Global postmenopausal osteoporosis market 2015-2020 ($ billions)
  • Exhibit 10: Global contraceptives market 2015-2020 ($ billions)
  • Exhibit 11: Global infertility market 2015-2020 ($ billions)
  • Exhibit 12: Global menopause market 2015-2020 ($ billions)
  • Exhibit 13: Global endometriosis market 2015-2020 ($ billions)
  • Exhibit 14: Global polycystic ovary syndrome market 2015-2020 ($ millions)
  • Exhibit 15: Global women's health market geographical segmentation 2015
  • Exhibit 16: Global women's health market geographical segmentation 2015-2020 ($ billions)
  • Exhibit 17: Women's health market in Americas 2015-2020 ($ billions)
  • Exhibit 18: Women's health market in Europe 2015-2020 ($ billions)
  • Exhibit 19: Women's health market in APAC 2015-2020 ($ billions)
  • Exhibit 20: Women's health market in MEA 2015-2020 ($ billions)
  • Exhibit 21: Average annual per capita growth in health spending and share of GDP in emerging countries and OECD for 2013-2014
  • Exhibit 22: Impact of drivers
  • Exhibit 23: Impact of drivers and challenges
  • Exhibit 24: Companies focusing on women's health
  • Exhibit 25: Allergan: Key takeaways
  • Exhibit 26: Bayer HealthCare: Key takeaways
  • Exhibit 27: Merck: Key takeaways
  • Exhibit 28: Pfizer: Key takeaways
  • Exhibit 29: Teva Pharmaceuticals: Key takeaways
Back to Top